» Articles » PMID: 23212923

Critical Role of S1PR1 and Integrin β4 in HGF/c-Met-mediated Increases in Vascular Integrity

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2012 Dec 6
PMID 23212923
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Vascular endothelial cell (EC) barrier integrity is critical to vessel homeostasis whereas barrier dysfunction is a key feature of inflammatory disorders and tumor angiogenesis. We previously reported that hepatocyte growth factor (HGF)-mediated increases in EC barrier integrity are signaled through a dynamic complex present in lipid rafts involving its receptor, c-Met. We extended these observations to confirm that S1PR1 (sphingosine 1-phosphate receptor 1) and integrin β4 (ITGB4) are essential participants in HGF-induced EC barrier enhancement. Immunoprecipitation experiments demonstrated HGF-mediated recruitment of c-Met, ITGB4 and S1PR1 to caveolin-enriched lipid rafts in human lung EC with direct interactions of c-Met with both S1PR1 and ITGB4 accompanied by c-Met-dependent S1PR1 and ITGB4 transactivation. Reduced S1PR1 expression (siRNA) attenuated both ITGB4 and Rac1 activation as well as c-Met/ITGB4 interaction and resulted in decreased transendothelial electrical resistance. Furthermore, reduced ITGB4 expression attenuated HGF-induced c-Met activation, c-Met/S1PR1 interaction, and effected decreases in S1P- and HGF-induced EC barrier enhancement. Finally, the c-Met inhibitor, XL880, suppressed HGF-induced c-Met activation as well as S1PR1 and ITGB4 transactivation. These results support a critical role for S1PR1 and ITGB4 transactivation as rate-limiting events in the transduction of HGF signals via a dynamic c-Met complex resulting in enhanced EC barrier integrity.

Citing Articles

Increased Kindlin-2 via SMURF1 Inhibition Attenuates Endothelial Permeability and Acute Lung Injury.

Chen W, Epshtein Y, Vagts C, Cress A, Jacobson J Int J Mol Sci. 2025; 26(5).

PMID: 40076507 PMC: 11899570. DOI: 10.3390/ijms26051880.


The MET Oncogene Network of Interacting Cell Surface Proteins.

Gallo S, Folco C, Crepaldi T Int J Mol Sci. 2025; 25(24.

PMID: 39769452 PMC: 11728269. DOI: 10.3390/ijms252413692.


Dysfunctional S1P/S1PR1 signaling in the dentate gyrus drives vulnerability of chronic pain-related memory impairment.

Cui M, Pan X, Fan Z, Wu S, Ji R, Wang X Elife. 2024; 13.

PMID: 39699949 PMC: 11658773. DOI: 10.7554/eLife.99862.


A Razor's Edge: Vascular Responses to Acute Inflammatory Lung Injury/Acute Respiratory Distress Syndrome.

Price D, Garcia J Annu Rev Physiol. 2024; 86:505-529.

PMID: 38345908 PMC: 11259086. DOI: 10.1146/annurev-physiol-042222-030731.


Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1 with CD8/PD-1.

Ma S, Liu J, Jia R, Deng W, Jia J Biomolecules. 2023; 13(6).

PMID: 37371594 PMC: 10296360. DOI: 10.3390/biom13061014.


References
1.
Abdel-Ghany M, Cheng H, Elble R, Pauli B . Focal adhesion kinase activated by beta(4) integrin ligation to mCLCA1 mediates early metastatic growth. J Biol Chem. 2002; 277(37):34391-400. DOI: 10.1074/jbc.M205307200. View

2.
Soderberg O, Gullberg M, Jarvius M, Ridderstrale K, Leuchowius K, Jarvius J . Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 2006; 3(12):995-1000. DOI: 10.1038/nmeth947. View

3.
Danilkovitch-Miagkova A, Zbar B . Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. J Clin Invest. 2002; 109(7):863-7. PMC: 150937. DOI: 10.1172/JCI15418. View

4.
Chen W, Sammani S, Mitra S, Ma S, Garcia J, Jacobson J . Critical role for integrin-β4 in the attenuation of murine acute lung injury by simvastatin. Am J Physiol Lung Cell Mol Physiol. 2012; 303(4):L279-85. PMC: 3423831. DOI: 10.1152/ajplung.00361.2011. View

5.
Eder J, Shapiro G, Appleman L, Zhu A, Miles D, Keer H . A phase I study of foretinib, a multi-targeted inhibitor of c-Met and vascular endothelial growth factor receptor 2. Clin Cancer Res. 2010; 16(13):3507-16. DOI: 10.1158/1078-0432.CCR-10-0574. View